This description is a summary of our understanding of the job description. Click on 'Apply' button to find out more.

Role Description

We are seeking a Director of Patient Services who will be responsible for the strategic oversight and continuous evolution of Neurotech’s patient support program. This role will lead the execution and optimization of high-impact services to ensure patients receive timely coordinated access to therapy. The Director manages third-party vendors, monitors operational performance, and works cross-functionally to enhance the overall patient experience, ensure compliance, and remove barriers to access. This position reports to the Sr. Director of Patient Services.

This position is a remote position.

• Lead the day-to-day management of the patient support program(s) to ensure coordinated access to Neurotech’s Encapsulated Cell Technology.
• Provide strategic oversight and management of third-party vendors to ensure service level agreement adherence, quality, consistency, and efficiency in service delivery.
• Lead the ongoing evaluation and refinement of the patient support program strategy aligning the efforts of the broad cross-functional team to facilitate high-impact interactions with targeted stakeholders.
• Partner with commercial colleagues in the development of market research and analytical projects. Implement initiatives that maintain a detailed understanding of key stakeholder needs with a long-range approach to brand positioning.
• Collaborate with the Trade Director to ensure the coordination and alignment between Patient Support and Trade Partners.
• Closely monitor competitive activities and stakeholder experience to develop and implement strategies to proactively meet competitive threats.
• Create, monitor, and report on all relevant metrics of commercial initiatives.
• Foster a team culture of engagement, accountability, collaboration, innovation, sense of urgency to serve patient needs and achieving Neurotech corporate vision.
• Complete ad-hoc projects and responsibilities as requested and assigned.

Qualifications

• Proven experience in Patient and HUB Services, with a record of driving financial results in highly competitive markets.
• 7 – 10 years of related physician, payor, and patient services experience in the pharmaceutical/biotech industry.
• Bachelor’s degree required, MBA or other advanced degree preferred.
• Product launch experience in rare/orphan diseases is a must. Gene and Cell therapies, Hospital, Buy-and-Bill and Medicare Part D products; experience preferred.
• Flexible, adaptable, diplomatic, and able to effectively deal and manage through ambiguity.
• Possesses a good blend of strategic and operational experience with the ability to see the big picture and strong attention to detail.
• Effective communication skills with the ability to present ideas, get buy-in and drive consensus within the commercial organization and across project teams.
• Demonstrated successful experience in a fast-paced entrepreneurial environment.
• Strategic leadership and operational execution particularly in areas like access to therapy, patient education, case management and cross functional collaboration.
• Outstanding project and budget management skills and experience managing multiple vendors.
• Ability to travel as part of position (approximately 25% required).

Company Description

Neurotech Pharmaceuticals, Inc. is a private biotech company located in Cumberland, RI and Needham, MA, within the realm of Greater Boston’s vast biotechnology landscape. Since our inception more than 20 years ago, our focus has been on developing and commercializing transformative therapies for chronic eye diseases. The core platform technology, Encapsulated Cell Therapy (ECT), is a first-in-class drug delivery platform designed to slow the progression of chronic eye diseases. Neurotech’s first commercial product, ENCELTO TM (revakinagene taroretcel-lwey), is approved in the United States for the treatment of adults with idiopathic Macular Telangiectasia Type 2 (MacTel). Encapsulated cell-based gene therapy is designed to provide long-term, sustained delivery of therapeutic proteins for the treatment of chronic eye diseases.